KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.470 $0.470 Thursday, 17th Aug 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470.
90 days $0.470 $0.470
52 weeks $0.460 $3.07

Historical Celyad SA prices

Date Open High Low Close Volume
Mar 08, 2016 $43.79 $43.79 $43.79 $43.79 400
Mar 07, 2016 $44.68 $45.19 $42.50 $44.73 8 700
Mar 04, 2016 $43.51 $43.82 $42.23 $43.27 5 300
Mar 03, 2016 $43.95 $43.95 $42.49 $43.18 2 400
Mar 02, 2016 $47.68 $47.68 $43.94 $43.94 600
Mar 01, 2016 $43.90 $43.98 $43.46 $43.98 3 200
Feb 29, 2016 $40.00 $41.14 $39.99 $41.10 1 800
Feb 26, 2016 $38.61 $39.88 $38.60 $38.88 600
Feb 25, 2016 $37.92 $39.80 $37.47 $38.60 1 100
Feb 24, 2016 $36.01 $39.80 $36.01 $38.76 2 000
Feb 23, 2016 $37.83 $39.97 $37.83 $38.06 600
Feb 22, 2016 $36.92 $38.20 $36.92 $38.05 1 900
Feb 19, 2016 $37.48 $37.48 $36.92 $36.92 1 400
Feb 18, 2016 $37.44 $39.10 $35.47 $38.06 8 800
Feb 17, 2016 $36.00 $37.11 $35.06 $36.64 4 700
Feb 16, 2016 $34.50 $35.53 $34.50 $35.53 4 200
Feb 12, 2016 $34.04 $35.09 $32.81 $34.01 8 600
Feb 11, 2016 $35.00 $35.01 $33.03 $33.46 3 100
Feb 10, 2016 $36.19 $36.19 $34.50 $34.50 4 800
Feb 09, 2016 $34.73 $37.30 $34.73 $36.50 6 900
Feb 08, 2016 $38.50 $38.50 $35.97 $36.45 2 500
Feb 05, 2016 $35.94 $39.00 $35.94 $38.80 2 100
Feb 04, 2016 $37.99 $37.99 $34.98 $34.98 600
Feb 03, 2016 $34.50 $34.50 $34.01 $34.45 6 600
Feb 02, 2016 $34.70 $35.20 $34.10 $34.45 10 400
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT